Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PAM | P19021 | 2/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17914317 | 0.95 | DGKA (0.65) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL1033327 | 0.95 | DGKA (0.64) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL28922182 | 0.93 | DGKA (0.68) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL13343463 | 0.93 | ALDH1A1 (0.58) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL13751390 | 0.92 | DGKA (0.57) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL813660 | 0.91 | DGKA (0.58) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL813905 | 0.91 | DGKA (0.58) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL12417283 | 0.90 | DGKA (0.59) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL9903196 | 0.89 | DGKA (0.57) | DGKAALDH1A1DNM1TSHRPRSS1 | |
| SCHEMBL17998754 | 0.89 | DGKA (0.57) | DGKAALDH1A1DNM1TSHRPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180112033-A1 | POLYESTER NANOGEL CORE STAR POLYMERS FOR DELIVERY OF THERAPEUTIC AGENTS | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2018-04-26 | — | — | US | disclosed |
| US-8765098-B2 | Star polymers, methods of preparation thereof, and uses thereof | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2014-07-01 | — | — | US | disclosed |
| US-20110243848-A1 | STAR POLYMERS, METHODS OF PREPARATION THEREOF, AND USES THEREOF | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110243848-A1 | STAR POLYMERS, METHODS OF PREPARATION THEREOF, AND USES THEREOF | AS3MT, STARD7, MCM5 | DGKA 1441/4885ALDH1A1 4841/4885DNM1 3376/4885 |
| US-20180112033-A1 | POLYESTER NANOGEL CORE STAR POLYMERS FOR DELIVERY OF THERAPEUTIC AGENTS | STARD10, STARD7, ABCB7 | DGKA 2464/4885ALDH1A1 3145/4885DNM1 3787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.